Executive summary Despite substantial progress in reducing the global impact of many non-
communicable diseases, including heart disease and cancer, morbidity and mortality due to …

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality
worldwide, and the burden of the disorder will continue to increase over the next 20 years …

Although chronic obstructive pulmonary disease (COPD) is a major global health problem
with a rising incidence and morbidity, few pharmacotherapeutic advances have been made …

No currently available treatments have been shown to slow the progression of chronic
obstructive pulmonary disease (COPD) or suppress the inflammation in small airways and …

On Nov 14, 2022, the Global Initiative for Chronic Obstructive Lung Disease (GOLD)
published their 2023 global strategy for the diagnosis, management, and prevention of …

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death
worldwide. COPD, however, is a heterogeneous collection of diseases with differing causes …

Chronic obstructive pulmonary disease (COPD) continues to be an important cause of
morbidity, mortality, and health-care costs worldwide. It is a global health issue, with …

Results of epidemiological studies have shown that chronic obstructive pulmonary disease
(COPD) is frequently associated with comorbidities, the most serious and prevalent being …

Chronic obstructive pulmonary disease (COPD) is a chronic disorder with substantial
comorbidity and major effects attributable to the high morbidity and mortality rates. Despite …

Chronic obstructive pulmonary disease (COPD) is a common, complex, and heterogeneous
disorder that is responsible for substantial and growing morbidity, mortality, and health-care …